ACUTE MYELOID LEUKAEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKAEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to keep leukemia at bay after remission
Disease control Recruiting nowThis study tests whether a combination of two drugs (cytarabine and venetoclax) can help adults with acute myeloid leukemia (AML) stay in remission longer. Participants are 18 to 60 years old who achieved complete remission after chemotherapy but cannot get a bone marrow transpla…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New hope for tough leukemia: experimental drug combo aims for remission
Disease control Recruiting nowThis study tests a new drug, L-Annamycin, combined with standard chemotherapy (cytarabine) in adults whose acute myeloid leukemia (AML) has returned or not responded to one prior treatment. The goal is to see if the combination can achieve complete remission (no signs of cancer) …
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2, PHASE3 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo aims to wipe out lingering leukemia cells before they return
Disease control Recruiting nowThis study tests whether a new combination of three drugs (tagraxofusp, azacitidine, and venetoclax) can safely eliminate leftover leukemia cells that are not visible under a microscope in adults with acute myeloid leukemia (AML). These hidden cells can cause the cancer to come b…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New study aims to uncover hidden clues in blood cancers
Knowledge-focused Recruiting nowThis study is for people with acute myeloid leukemia (AML) or follicular lymphoma. Researchers will collect blood and leftover tissue samples during routine care to look for genetic markers that may predict how the disease progresses or responds to treatment. The goal is to bette…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated May 17, 2026 02:04 UTC
-
New study aims to personalize chemo dosing for blood cancer patients
Knowledge-focused Recruiting nowThis study looks at how kidney function and race/ethnicity affect the way the drug treosulfan works in people with acute myeloid leukemia or myelodysplastic syndrome who are getting a stem cell transplant. The goal is to find the safest dose for those with kidney problems. About …
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE1 • Sponsor: medac GmbH • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC